Collagen‐membrane‐covered matrix‐associated chondrocyte implantation improves safety over periosteum‐covered MACI for large knee cartilage defects: A real‐world data analysis in the registry study
Open Access
- 24 February 2026
- journal article
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
Abstract
Purpose: This registry study aimed to evaluate the safety and effectiveness of collagen membrane‐covered matrix‐associated autologous chondrocyte implantation (cMACI) versus periosteum‐covered MACI (pMACI) for large knee cartilage defects (Outerbridge III–IV, ≥4 cm²) in the femorotibial and/or patellofemoral joints with a minimum 2‐year follow‐up. Methods: The safety analysis included 662 knees from 645 patients (mean age: 41.6 ± 14.0 years) with trauma (586 knees, 88.5%) or osteochondritis dissecans (76 knees, 11.5%). Mean final defect size after debridement was 6.6 ± 3.6 cm² (range: 4.0–38 cm²), with ≥4 cm² in 101 knees (15.3%) receiving cMACI and 561 (84.7%) receiving pMACI. Adverse events (AEs) were assessed through physical examination, magnetic resonance imaging (MRI) and arthroscopy. AEs rates were compared between cMACI and pMACI. The effectiveness was assessed using the Lysholm Knee Score (LKS) and the Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6, 12 and 24 months postoperatively. A mixed‐effects model for repeated measures was used for comparative analysis. Results: Analyses showed no significant differences in patient characteristics between groups, except for age (older in the cMACI group), sex (predominantly female), disease aetiology (predominantly trauma) and meniscectomy prevalence (lower). cMACI showed reduced rates of graft hypertrophy (1.0% vs. 10.7%, p = 0.0176), delamination (5.9% vs. 14.1%, p = 0.0350), ossification (0% vs. 2.3%, not applicable), contracture (1.0% vs. 8.7%, p = 0.0302) and treatment failure (3% vs. 9%, p = 0.0037). The per‐protocol set assessing effectiveness included 509 knees (cMACI/pMACI: 70/439), with no significant differences in patient characteristics between groups. The results demonstrated similar postoperative improvements in LKS and KOOS in both groups. Conclusion: cMACI showed superior safety compared with pMACI for large cartilage defects, with similarly improved outcomes in approximately 75% of patients. These findings suggest that the collagen membrane may address periosteum‐related AEs and treatment failures in MACI. Level of Evidence: Level II.Keywords
This publication has 46 references indexed in Scilit:
- Autologous chondrocyte implantation, matrix‐induced autologous chondrocyte implantation, osteochondral autograft transplantation and osteochondral allograft improve knee function and pain with considerations for patient and cartilage defects characteristics: A systematic review and meta‐analysisKnee Surgery, Sports Traumatology, Arthroscopy, 2024
- Hydrogel‐based and spheroid‐based autologous chondrocyte implantation of the knee show similar 2‐year functional outcomes: An analysis based on the German Cartilage Registry (KnorpelRegister DGOU)Knee Surgery, Sports Traumatology, Arthroscopy, 2024
- Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorshipJournal of Cartilage & Joint Preservation, 2021
- Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 yearsKnee Surgery, Sports Traumatology, Arthroscopy, 2020
- Revision surgery after third generation autologous chondrocyte implantation in the kneeInternational Orthopaedics, 2015
- Cartilage failures. Systematic literature review, critical survey analysis, and definitionKnee Surgery, Sports Traumatology, Arthroscopy, 2014
- First-generation versus second-generation autologous chondrocyte implantation for treatment of cartilage defects of the knee: a matched-pair analysis on long-term clinical outcomeInternational Orthopaedics, 2014
- The John Insall Award: A Minimum 10-year Outcome Study of Autologous Chondrocyte ImplantationClinical Orthopaedics and Related Research, 2014
- First‐Generation Autologous Chondrocyte Implantation in Patients With Cartilage Defects of the Knee: 7 to 14 Years' Clinical and Magnetic Resonance Imaging Follow‐up EvaluationArthroscopy, 2012
- Marrow stimulation and chondrocyte transplantation using a collagen matrix for cartilage repairOsteoarthritis and Cartilage, 2005